Ascendis Pharma A/S
ASND | NASDAQ
$251.27
-$1.73 (-0.68%)
At close: Oct 30, 2026, 4:00 PM ET
$246.24
-$5.03 (-2.00%)
Pre-market:
Nov 2, 2026, 9:20 AM ET
Market Data
Market Cap $16.53B
Enterprise Value $14.11B
Beta 0.37
Average Volume 724.75K
Shares Outstanding (Diluted) 68.32M
Shares Change YoY 6.9%
Institutional Ownership N/A
Exchange NASDAQ
ISIN DK0060615755
Price Performance
Price Change 1M 10.3%
Price Change 3M 3.0%
Price Change 6M 13.7%
Price Change YTD 17.8%
Price Change 1Y 24.6%
Price Change 3Y 181.3%
Price Change 5Y 65.7%
1M CAGR (ann.) 6.2%
1Y CAGR (ann.) 22.1%
5Y CAGR (ann.) 11.7%
All-Time CAGR 29.4%
Valuation
PE Ratio 18.81
Forward PE 25.79
PEG Ratio 0.03
Forward PEG -0.03
PS Ratio 13.44
Forward PS 7.40
PB Ratio 10.08
P/FCF Ratio 42.08
P/Adj. FCF Ratio 46.28
P/OCF Ratio 39.45
EV/Sales 13.39
EV/EBIT 233.70
EV/EBITDA 180.66
EV/FCF 41.89
Earnings Yield 5.1%
FCF Yield 2.3%
Adj. FCF Yield 2.1%
Financial Health
Net Cash €362.04M
Total Debt €449.89M
Cash & Short-Term Investments €811.92M
Total Assets €2.29B
Current Ratio 2.99
Quick Ratio 2.32
Debt / Equity Ratio 0.31
Debt / EBITDA 5.76
Debt / FCF 1.34
OCF / Debt 0.78
Interest Coverage 0.67
Altman Z-Score 10.11
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 90.2%
Operating Profit Margin 10.4%
EBITDA Margin 7.4%
Net Profit Margin 71.7%
FCF Margin 31.9%
Adj. FCF Margin 29.1%
SBC / Revenue 2.9%
SBC Impact (per share) -9.1%
Returns
Return on Assets 33.1%
Return on Equity 190.4%
Return on Invested Capital 5.8%
Return on Capital Employed 6.0%
Return on Tangible Assets 33.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 106.8%
Revenue CAGR 5Y 190.9%
Revenue CAGR 10Y 66.4%
EPS CAGR 3Y 1584.5%
EPS CAGR 5Y 108.8%
EPS CAGR 10Y 11.4%
FCF CAGR 3Y 605.9%
FCF CAGR 5Y 84.5%
FCF CAGR 10Y 3.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 15
EPS Growth Next 3Y 12.6%
Revenue Growth Next 3Y 41.6%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) $1.00
EPS Growth Est (next Q) -176.1%
Revenue Est (next Q) $462.87M
Revenue Growth Est (next Q) 64.7%
Fair Value Estimates
Graham Number $86.61
Graham Upside -65.5%
Lynch Fair Value $333.90
Lynch Upside 32.9%
Price Target $307.85
Price Target Upside 22.5%
Cash Flow
Operating Cash Flow €351.32M
Free Cash Flow €336.9M
Adj. Free Cash Flow €306.26M
FCF Per Share $5.24
OCF Per Share $5.46
OCF/S Ratio 33.3%
Income Statement
Revenue €1.05B
Gross Profit €950.9M
Operating Income €109.45M
EBITDA €78.13M
Net Income €755.85M
EPS (Diluted) $11.45
Revenue / Employee $886.77K
Profit / Employee $635.7K
Employees 1,189
Add to Watchlist
Select watchlists to add or remove ASND